Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 759 |
|
|||||
| News | - | ||||||
| Day High | 20.85 | Low High |
|||||
| Day Low | 20.75 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Synchronoss Technologies Inc | SNCRL | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 20.85 | 15:00:08 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 20.85 | 20.75 | 20.85 | 20.85 | 20.85 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 28 | 759 | US$ 20.85 | US$ 15,825 | - | 16.40 - 22.60 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 1 | US$ 20.70 | USD |
Synchronoss Technologies Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 22.63M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Synchronoss Technologies News
Real-Time news about Synchronoss Technologies Inc (NASDAQ): 0 recent articles
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SNCRL Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 21.00 | 21.00 | 20.50 | 20.99 | 3,374 | -0.15 | -0.71% |
| 1 Month | 21.10 | 21.28 | 17.55 | 20.90 | 5,724 | -0.25 | -1.18% |
| 3 Months | 19.90 | 22.60 | 17.55 | 21.00 | 6,370 | 0.95 | 4.77% |
| 6 Months | 17.73 | 22.60 | 17.55 | 19.83 | 11,372 | 3.12 | 17.60% |
| 1 Year | 18.39 | 22.60 | 16.40 | 19.12 | 8,672 | 2.46 | 13.38% |
| 3 Years | 24.95 | 25.45 | 15.00 | 22.43 | 12,402 | -4.10 | -16.43% |
| 5 Years | 24.95 | 25.45 | 15.00 | 22.43 | 12,402 | -4.10 | -16.43% |
Synchronoss Technologies Description
| Synaptogenix, Inc. is a biopharmaceutical company. The Company is principally focused on developing therapeutics for patients with neurodegenerative diseases and developmental disorders. The Company is focused on developing a product platform based on a drug candidate called Bryostatin-1, which is synthesized from a natural product (bryostatin) that is isolated from a marine invertebrate organism, for the treatment of Alzheimer's disease (AD). Bryostatin-1 is a Protein Kinase C Epsilon (PKC e), a and e activator that was originally developed as a potential anticancer drug. The Company is evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis (MS), and Niemann-Pick Type C disease. |
